4 Programs

Centre may renegotiate vaccine prices with SII and Bharat Biotech – The Indian Express

admin
  1. Centre may renegotiate vaccine prices with SII and Bharat Biotech  The Indian Express
  2. Amid row, Bharat Biotech says it will conduct phase 4 trial of Covaxin, phase 3 data to be out in July  Hindustan Times
  3. Central govt’s large order may compensate SII, Bharat Biotech for loss of high-priced states orders  Moneycontrol
  4. A premium price cap on Covaxin is inexplicable  Mint
  5. India Raises Concerns Over Demand for Re-vaccination of US-bound Students as Cov  News18
  6. View Full coverage on Google News